TB-500
PulseAugur coverage of TB-500 — every cluster mentioning TB-500 across labs, papers, and developer communities, ranked by signal.
-
FDA faces decision on popular peptides amid safety and efficacy concerns
The FDA is facing a critical decision regarding the authorization of six popular but experimental peptides, which are increasingly being used for health, fitness, and longevity despite limited scientific evidence. Onlin…
-
FDA advisers back peptides despite safety concerns · 1 source tracked
A panel advising the U.S. Food and Drug Administration has narrowly recommended easing restrictions on several peptides, including BPC-157 and TB-500, which are popular among wellness influencers and celebrities. Despit…
-
FDA panel to review peptides, potentially opening $3B market
A Food and Drug Administration (FDA) panel is set to review seven peptides, potentially paving the way for their legal production and sale. The current market for these unproven substances operates in a regulatory gray …
-
FDA reviews popular peptides amid safety and efficacy concerns · 2 sources tracked
The U.S. Food and Drug Administration (FDA) is set to review seven peptides for potential approval for compounding by pharmacies. These peptides, including BPC-157, TB-500, and Semax, are popular in longevity and wellne…
-
FDA peptide vote could unlock new telehealth market, mirroring Ozempic boom
The FDA's upcoming vote on seven peptides, including BPC-157 and TB-500, could legitimize a new multibillion-dollar market for wellness injectables. Telehealth companies like Hims & Hers, which previously profited from …
-
Longevity influencers challenge medical expertise with unregulated peptide advice
Social media influencers are increasingly disseminating information about longevity medicine, including complex peptide treatments, to large audiences. This trend bypasses traditional medical expertise, as patients ofte…